Cargando…

The Clinical Implications of Tumor Mutational Burden in Osteosarcoma

BACKGROUND: Osteosarcoma (OTS) is aggressive bone malignancy without well-recognized prognosis biomarker. Tumor mutational burden (TMB) has been proved as effective biomarker in predicting clinical outcomes in several cancer types. However, its prognostic value in OTS remains unknown. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Lu, Yang, Yufei, Guo, Wei, Che, Dongxue, Xu, Jie, Sun, Xin, Liu, Kuisheng, Ren, Tingting, Liu, Xingyu, Yang, Yi, Ji, Tao, Tang, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059407/ https://www.ncbi.nlm.nih.gov/pubmed/33898301 http://dx.doi.org/10.3389/fonc.2020.595527

Ejemplares similares

Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy
por: Luo, Zhong-Wei, et al.
Publicado: (2020)

Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma
por: Xu, Jiuhui, et al.
Publicado: (2023)

MicroRNAs Expression Patterns Predict Tumor Mutational Burden in Colorectal Cancer
por: Huang, Jiahao, et al.
Publicado: (2021)

Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trial
por: Xie, Lu, et al.
Publicado: (2020)

Systematic assessment and optimizing algorithm of tumor mutational burden calculation and their implications in clinical decision-making
por: Sun, Daqiang, et al.
Publicado: (2022)

Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy
por: Zeng, Lisi, et al.
Publicado: (2022)

Next-Generation Sequencing Reveals High Uncommon EGFR Mutations and Tumour Mutation Burden in a Subgroup of Lung Cancer Patients
por: Guo, Gang, et al.
Publicado: (2021)

Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden
por: Yuan, Hong, et al.
Publicado: (2021)

Complete remission of metastatic osteosarcoma using combined modality therapy: a retrospective analysis of unselected patients in China
por: Xie, Lu, et al.
Publicado: (2021)

Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma
por: Hu, Xin, et al.
Publicado: (2022)

Genomic Analysis Revealed Mutational Traits Associated with Clinical Outcomes in Osteosarcoma
por: Chi, Xiying, et al.
Publicado: (2021)

Insight Into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication
por: Niu, Jianfang, et al.
Publicado: (2019)

FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer
por: Guo, Zixin, et al.
Publicado: (2021)

Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes
por: Teng, Xu, et al.
Publicado: (2023)

PKIB involved in the metastasis and survival of osteosarcoma
por: Wan, Rongxue, et al.
Publicado: (2022)

Osteosarcoma and Metastasis
por: Sheng, Gaohong, et al.
Publicado: (2021)

Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
por: Li, Jianhao, et al.
Publicado: (2020)

miRNA-Based Signature Associated With Tumor Mutational Burden in Colon Adenocarcinoma
por: Xue, Weijie, et al.
Publicado: (2021)

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma
por: Yin, Wen, et al.
Publicado: (2020)

Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment
por: Xie, Duoli, et al.
Publicado: (2022)

Identification of Potential Therapeutic Targets and Immune Cell Infiltration Characteristics in Osteosarcoma Using Bioinformatics Strategy
por: Niu, Jianfang, et al.
Publicado: (2020)

High tumor mutation burden indicates better prognosis in colorectal cancer patients with KRAS mutations
por: Wang, Jianlei, et al.
Publicado: (2022)

Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma
por: Song, Jiaxun, et al.
Publicado: (2022)

Induction of Pyroptosis and Its Implications in Cancer Management
por: Wang, Yan-Yang, et al.
Publicado: (2019)

Emerging Roles and Potential Biological Value of CircRNA in Osteosarcoma
por: Liu, Jiamei, et al.
Publicado: (2020)

Aberrant Expression of PAFAH1B3 Affects Proliferation and Apoptosis in Osteosarcoma
por: Fan, Jian, et al.
Publicado: (2021)

Implications of Habitual Alcohol Intake With the Prognostic Significance of Mean Corpuscular Volume in Stage II-III Colorectal Cancer
por: Liu, Qi, et al.
Publicado: (2021)

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2021)

PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse
por: Zheng, Bingxin, et al.
Publicado: (2018)

Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma
por: Liu, Kuisheng, et al.
Publicado: (2017)

Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study
por: Wang, Jiaqiang, et al.
Publicado: (2023)

KIF21B Expression in Osteosarcoma and Its Regulatory Effect on Osteosarcoma Cell Proliferation and Apoptosis Through the PI3K/AKT Pathway
por: Ni, Songjia, et al.
Publicado: (2021)

Correction to: PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse
por: Zheng, Bingxin, et al.
Publicado: (2018)

Ailanthone Inhibits Proliferation, Migration and Invasion of Osteosarcoma Cells by Downregulating the Serine Biosynthetic Pathway
por: Zhang, Yawen, et al.
Publicado: (2022)

Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways
por: Ren, Tingting, et al.
Publicado: (2019)

High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification
por: Jiang, Xiaohong, et al.
Publicado: (2023)

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)

Downregulation of miR-22 Contributes to Epithelial-Mesenchymal Transition in Osteosarcoma by Targeting Twist1
por: Zhu, Shu-tao, et al.
Publicado: (2020)

Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
por: Xiang, Yubo, et al.
Publicado: (2023)

CircNRIP1 Encapsulated by Bone Marrow Mesenchymal Stem Cell–Derived Extracellular Vesicles Aggravates Osteosarcoma by Modulating the miR-532-3p/AKT3/PI3K/AKT Axis
por: Shi, Zuowei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l10ll7jpej2vtqpud23ak9cl5l